451
Views
9
CrossRef citations to date
0
Altmetric
Therapy

Tiotropium added to low- to medium-dose inhaled corticosteroids (ICS) versus low- to medium-dose ICS alone for adults with mild to moderate uncontrolled persistent asthma: A systematic review and meta-analysis

, MPharm, , MPharm & , MS
Pages 69-78 | Received 25 Aug 2017, Accepted 01 Jan 2018, Published online: 08 Feb 2018

References

  • GINA. Global Strategy for Asthma Management and Prevention. GINA[Internet]. 2017. [cited 2017 August 3]. Available from: http://ginasthma.org/2017-gina-report-global-strategy-for-asthma-management-and-prevention/.
  • WHO. Asthma. WHO[Internet]. 2017. [cited 2017 August 3]. Available from: http://www.who.int/mediacentre/factsheets/fs307/en/.
  • Lee YJ, Kwon SH, Hong SH, Nam JH, Song HJ, Lee JS, et al. Health care utilization and direct costs in mild, moderate, and severe adult asthma: a descriptive study using the 2014 South Korean Health Insurance Database. Clin Ther. 2017;39(3):527–36. doi:10.1016/j.clinthera.2017.01.025.
  • Network TGA. Global Asthma Report 2014. The Global Asthma Network[Internet]. 2014. [cited 2017 August 3]. Available from: http://www.globalasthmareport.org/.
  • Anderson DE, Kew KM, Boyter AC. Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for adults with asthma. Cochrane Database Syst Rev. 2015(8). Article. No.: CD011397. DOI:10.1002/14651858.CD011397.pub2.
  • Evans DJ, Kew KM, Anderson DE, Boyter AC. Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus higher dose ICS for adults with asthma. Cochrane Database Syst Rev. 2015(7) Article. No.:CD011437. DOI: 10.1002/14651858.CD011437.pub2.
  • Rodrigo GJ, Castro-Rodriguez JA. What is the role of tiotropium in asthma?: a systematic review with meta-analysis. Chest. 2015;147(2):388–96. doi:10.1378/chest.14-1698.
  • Vogelberg C, Engel M, Moroni-Zentgraf P, Leonaviciute-Klimantaviciene M, Sigmund R, Downie J, et al. Tiotropium in asthmatic adolescents symptomatic despite inhaled corticosteroids: a randomised dose-ranging study. Respir Med. 2014;108(9):1268–76. doi:10.1016/j.rmed.2014.06.011.
  • Bateman E, Kornmann O, Schmidt P, Pivovarova A, Engel M, Fabbri L. Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma. J Allergy Clin Immunol. 2011;128(2):315–22. doi:10.1016/j.jaci.2011.06.004.
  • clinicaltrials. Glossary of Common Site Terms. clinicaltrials[Internet]. 2017. [cited 2017 August 3] Available from: https://clinicaltrials.gov/ct2/about-studies/glossary
  • JPT H, S G. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration[Internet]. 2011 March [cited 2017 August 3]. Available from: www.handbook.cochrane.org.
  • Peters SP, Kunselman SJ, Icitovic N, Moore WC, Pascual R, Ameredes BT, et al. Tiotropium bromide step-up therapy for adults with uncontrolled asthma. New Engl J Med. 2010;363(18):1715–26. doi:10.1056/NEJMoa1008770.
  • Beeh K, Moroni-Zentgraf P, Ablinger O, Hollaenderova Z, Unseld A, Engel M, et al. Tiotropium Respimat® in asthma: a double-blind, randomised, dose-ranging study in adult patients with moderate asthma. Respir Res. 2014;15:61. doi:10.1186/1465-9921-15-61.
  • Timmer W, Moroni-Zentgraf P, Cornelissen P, Unseld A, Pizzichini E, Buhl R. Once-daily tiotropium Respimat(R) 5 mug is an efficacious 24-h bronchodilator in adults with symptomatic asthma. Respir Med. 2015;109(3):329–38. doi:10.1016/j.rmed.2014.12.005.
  • Paggiaro P, Halpin D, Buhl R, Engel M, Zubek V, Blahova Z, et al. The effect of tiotropium in symptomatic asthma despite low- to medium-dose inhaled corticosteroids: a randomized controlled trial. J Allergy Clin Immunol: In Pract. 2016;4(1):104–13.e2. doi:10.1016/j.jaip.2015.08.017.
  • Busse WW, Dahl R, Jenkins C, Cruz AA. Long-acting muscarinic antagonists: a potential add-on therapy in the treatment of asthma? Eur Respir Rev: An Off J Eur Respir Society. 2016;25(139):54–64. doi:10.1183/16000617.0052-2015.
  • Ding B, Small M. Disease burden of mild asthma: findings from a cross-sectional real-world survey. Adv Ther. 2017;34(5):1109–27. doi:10.1007/s12325-017-0520-0.
  • Anzueto A, Wise R, Calverley P, Dusser D, Tang W, Metzdorf N, et al. The Tiotropium safety and performance in respimat® (TIOSPIR®) trial: spirometry outcomes. Respir Res [Internet]. 2015;16:107. Available from: http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/075/CN-01092075/frame.html. doi:10.1186/s12931-015-0269-4.
  • Adams KS, Lowe DK. Tiotropium for adults with inadequately controlled persistent asthma. Ann pharmacother. 2013;47(1):117–23. doi:10.1345/aph.1R502.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.